Zhipu Luo

Zhipu Luo

Auto-generated profile, based on publicly available information

Zhipu Luo

MOE Key Laboratory of Geriatric Diseases and Immunology, Biomedical Basic Research Center, Institute of Molecular Enzymology, School of Life Sciences, Suzhou Medical College of Soochow University, Suzhou, PR China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Journal of Molecular Biology
Verified
Journal Article
Closed access
BZBaoyu Zhao
Baoyu Zhao
Sonu GandhiSonu Gandhi
Sonu Gandhi
CYCai Yuan
Cai Yuan
ZLZhipu Luo
Zhipu Luo
RLRui Li
Rui Li
Michael PlougMichael Ploug
Michael Ploug

20 February 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
LDLiyang Du
Liyang Du
DZDanping Zhang
Danping Zhang
ZLZhipu Luo
Zhipu Luo
ZLzhonghui lin
zhonghui lin
The cyclic oligoadenylates (cOAs) act as second messengers of the type III CRISPR immunity system through activating the auxiliary nucleases for indiscriminate RNA degradation. The cOA-degrading nucleases (ring nucleases) provide an ‘off-switch’ regulation of the signaling, thereby preventing cell dormancy or cell death. Here, we describe the crystal structures of the founding member of CRISPR-associated ring nuclease 1 (Crn1) Sso2081 from Saccharolobus solfataricus, alone, bound to phosphate ions or cA4 in both pre-cleavage and cleavage intermediate states. These structures together with biochemical characterizations establish the molecular basis of cA4 recognition and catalysis by Sso2081. The conformational changes in the C-terminal helical insert upon the binding of phosphate ions or cA4 reveal a gate-locking mechanism for ligand binding. The critical residues and motifs identified in this study provide a new insight to distinguish between cOA-degrading and -nondegrading CARF domain-containing proteins.

1 July 2022 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SCShanli Chen
Shanli Chen
CYCai Yuan
Cai Yuan
LJLongguang Jiang
Longguang Jiang
ZLZhipu Luo
Zhipu Luo
MHMingdong Huang
Mingdong Huang

5 November 2025 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
AYAizhen Yang
Aizhen Yang
YZYaqiong Zhang
Yaqiong Zhang
YSYaowei Sun
Yaowei Sun
MJMiao Jiang
Miao Jiang
YLYi Lu
Yi Lu
YWYi Wu
Yi Wu
Protein disulfide isomerases (PDIs) are a family of thiol oxidoreductases that catalyze the oxidation, reduction, and isomerization of disulfide bonds. While some PDIs enhance arterial thrombosis, their roles in coagulation system remain largely unknown. The effect of a thiol blocker NEM and a reducing agent DTT on FXII activity was measured by chromogenic assay, activated partial thromboplastin time (aPTT) and thrombin generation assay. Redox states of FXII disulfides were determined by thiol labeling and mass spectrometry. Functional disulfides were evaluated through cysteine mutagenesis of FXII and predicting structural function via molecular dynamics simulations. Thiol modification and kinetic trapping were used to identify ERp46 substrates. The inferior vena cava stenosis model assessed the roles of ERp46 and FXII in venous thrombosis. NEM significantly prolonged aPTT and inhibited FXIIa chromogenic activity, while DTT inhibited clotting, thrombin generation and substrate HK cleavage. Of the PDIs tested, only oxidized ERp46 enhanced FXII activity. Screening identified Cys513-Cys529 and Cys540-Cys571 as crucial disulfides for FXII function. Notably, half of Cys540-Cys571 were in partially disulfide-bonded form. ERp46 oxidized Cys540-Cys571 and increased FXII activity. In vivo, ERp46 deficiency reduced venous thrombus growth, with no additive effect observed in mice with combined ERp46 and FXII deficiency. Only wild-type FXII (FXII/WT) protein, not FXII/C540S-C571S mutant, restored venous thrombus growth in FXII deficient mice. These findings reveal a novel redox-regulatory mechanism for FXII activity and identify the critical role of ERp46 in oxidization of Cys540-Cys571 disulfide facilitating the activation of FXII and intrinsic coagulation pathway.

13 July 2022 in Crystals
Verified
Journal Article
Open access
PDF file
ZLZhipu Luo
Zhipu Luo
WGWeijie Gu
Weijie Gu
YWYichao Wang
Yichao Wang
YTYannan Tang
Yannan Tang
Dianfan LiDianfan Li
Dianfan Li
Heavy-atom soaking has been a major method for experimental phasing, but it has been difficult for membrane proteins, partly owing to the lack of available sites in the scarce soluble domain for non-invasive heavy-metal binding. The lipid cubic phase (LCP) has proven to be a successful method for membrane protein crystallization, but experimental phasing with LCP-grown crystals remains difficult, and so far, only 68 such structures were phased experimentally. Here, the selenourea was tested as a soaking reagent for the single-wavelength anomalous dispersion (SAD) phasing of crystals grown in LCP. Using a single crystal, the structure of the glycerol 3-phosphate acyltransferase (PlsY, ~21 kDa), a very hydrophobic enzyme with 80% membrane-embedded residues, was solved. Remarkably, a total of 15 Se sites were found in the two monomers of PlsY, translating to one selenourea-binding site per every six residues in the accessible extramembrane protein. Structure analysis reveals that surface-exposed selenourea sites are mostly contributed by mainchain amides and carbonyls. This low-specificity binding pattern may explain its high loading ratio. Importantly, both the crystal diffraction quality and the LCP integrity were unaffected by selenourea soaking. Taken together, selenourea presents a promising and generally useful reagent for heavy-atom soaking of membrane protein crystals grown in LCP.

17 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
DZDanping Zhang
Danping Zhang
SXShenjie Xu
Shenjie Xu
ZLZhipu Luo
Zhipu Luo
ZLzhonghui lin
zhonghui lin
Holliday junction resolution is a crucial process in homologous recombination and DNA double-strand break repair. Complete Holliday junction resolution requires two stepwise incisions across the center of the junction, but the precise mechanism of metal ion-catalyzed Holliday junction cleavage remains elusive. Here, we perform a metal ion-triggered catalysis in crystals to investigate the mechanism of Holliday junction cleavage by MOC1. We capture the structures of MOC1 in complex with a nicked Holliday junction at various catalytic states, including the ground state, the one-metal ion binding state, and the two-metal ion binding state. Moreover, we also identify a third metal ion that may aid in the nucleophilic attack on the scissile phosphate. Further structural and biochemical analyses reveal a metal ion-mediated allosteric regulation between the two active sites, contributing to the enhancement of the second strand cleavage following the first strand cleavage, as well as the precise symmetric cleavage across the Holliday junction. Our work provides insights into the mechanism of metal ion-catalyzed Holliday junction resolution by MOC1, with implications for understanding how cells preserve genome integrity during the Holliday junction resolution phase.